C60 Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-12-12

AUTHORS

Svitlana Prylutska, Iryna Grynyuk, Olga Matyshevska, Yuriy Prylutskyy, Maxim Evstigneev, Peter Scharff, Uwe Ritter

ABSTRACT

BackgroundDoxorubicin (Dox) is one of the most potent anticancer drugs, but its successful use is hampered by high toxicity caused mainly by generation of reactive oxygen species. One approach to protect against Dox-dependent chemical insult is combined use of the cytostatic drug with antioxidants. C60 fullerene has a nanostructure with both antioxidant and antitumor potential and may be useful in modulating cell responses to Dox.ObjectiveThe aim of this study was to estimate the antitumor effect and antioxidant enzyme activity of combined C60 fullerene and Dox (C60 + Dox) in the liver and heart of mice with Lewis lung carcinoma compared with Dox treatment alone.MethodsHighly stable pristine C60 fullerene aqueous colloid solution (concentration 1.0 mg/ml, average hydrodynamic diameter of nanoparticles 50 nm) was used in the study and characterized by means of atomic force microscopy (AFM). The in vivo investigation of C60-Dox action was performed via the standard methods of histological and enzyme activity analyses.ResultsDox (total dose 2.5 mg/kg) combined with C60 fullerene (total dose 25 mg/kg) in tumor-bearing animals resulted in tumor growth inhibition, prolongation of life, metastasis inhibition, and increased number of apoptotic tumor cells and was more effective than the corresponding course of Dox treatment alone. C60 fullerene demonstrated a protective effect against superoxide dismutase and glutathione peroxidase inhibition induced by Dox-dependent oxidative insult in the liver and heart.ConclusionCombined treatment with C60 + Dox is considered to be a promising approach for cancer chemotherapy. More... »

PAGES

333-340

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40268-014-0074-4

DOI

http://dx.doi.org/10.1007/s40268-014-0074-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045017571

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25504158


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antioxidants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Lewis Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colloids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Screening Assays, Antitumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Synergism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fullerenes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glutathione Peroxidase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanoparticles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Superoxide Dismutase", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601, Kyiv, Ukraine", 
          "id": "http://www.grid.ac/institutes/grid.34555.32", 
          "name": [
            "Joint Ukrainian-German Center on Nanobiotechnology, Kyiv, Ukraine", 
            "Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601, Kyiv, Ukraine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prylutska", 
        "givenName": "Svitlana", 
        "id": "sg:person.01265014537.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265014537.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601, Kyiv, Ukraine", 
          "id": "http://www.grid.ac/institutes/grid.34555.32", 
          "name": [
            "Joint Ukrainian-German Center on Nanobiotechnology, Kyiv, Ukraine", 
            "Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601, Kyiv, Ukraine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grynyuk", 
        "givenName": "Iryna", 
        "id": "sg:person.01042167742.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042167742.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601, Kyiv, Ukraine", 
          "id": "http://www.grid.ac/institutes/grid.34555.32", 
          "name": [
            "Joint Ukrainian-German Center on Nanobiotechnology, Kyiv, Ukraine", 
            "Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601, Kyiv, Ukraine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matyshevska", 
        "givenName": "Olga", 
        "id": "sg:person.01037270327.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037270327.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601, Kyiv, Ukraine", 
          "id": "http://www.grid.ac/institutes/grid.34555.32", 
          "name": [
            "Joint Ukrainian-German Center on Nanobiotechnology, Kyiv, Ukraine", 
            "Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601, Kyiv, Ukraine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prylutskyy", 
        "givenName": "Yuriy", 
        "id": "sg:person.0761452727.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761452727.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biology and Chemistry, Belgorod State University, 85 Pobedy Str., 308015, Belgorod, Russia", 
          "id": "http://www.grid.ac/institutes/grid.445984.0", 
          "name": [
            "Department of Biology and Chemistry, Belgorod State University, 85 Pobedy Str., 308015, Belgorod, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Evstigneev", 
        "givenName": "Maxim", 
        "id": "sg:person.01340542173.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340542173.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer Str. 25, 098693, Ilmenau, Germany", 
          "id": "http://www.grid.ac/institutes/grid.6553.5", 
          "name": [
            "Joint Ukrainian-German Center on Nanobiotechnology, Kyiv, Ukraine", 
            "Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer Str. 25, 098693, Ilmenau, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scharff", 
        "givenName": "Peter", 
        "id": "sg:person.0616413475.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616413475.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer Str. 25, 098693, Ilmenau, Germany", 
          "id": "http://www.grid.ac/institutes/grid.6553.5", 
          "name": [
            "Joint Ukrainian-German Center on Nanobiotechnology, Kyiv, Ukraine", 
            "Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer Str. 25, 098693, Ilmenau, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ritter", 
        "givenName": "Uwe", 
        "id": "sg:person.0664526675.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664526675.56"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1477-3155-4-14", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032470725", 
          "https://doi.org/10.1186/1477-3155-4-14"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12645-011-0020-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041423305", 
          "https://doi.org/10.1007/s12645-011-0020-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11051-005-9001-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026397920", 
          "https://doi.org/10.1007/s11051-005-9001-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00249-014-0960-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008871525", 
          "https://doi.org/10.1007/s00249-014-0960-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11427-012-4387-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027441736", 
          "https://doi.org/10.1007/s11427-012-4387-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/s1734-1140(09)70041-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035189147", 
          "https://doi.org/10.1016/s1734-1140(09)70041-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-0-387-76713-0_13", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044141474", 
          "https://doi.org/10.1007/978-0-387-76713-0_13"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00204-012-0859-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028227274", 
          "https://doi.org/10.1007/s00204-012-0859-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-12-12", 
    "datePublishedReg": "2014-12-12", 
    "description": "BackgroundDoxorubicin (Dox) is one of the most potent anticancer drugs, but its successful use is hampered by high toxicity caused mainly by generation of reactive oxygen species. One approach to protect against Dox-dependent chemical insult is combined use of the cytostatic drug with antioxidants. C60 fullerene has a nanostructure with both antioxidant and antitumor potential and may be useful in modulating cell responses to Dox.ObjectiveThe aim of this study was to estimate the antitumor effect and antioxidant enzyme activity of combined C60 fullerene and Dox (C60\u00a0+\u00a0Dox) in the liver and heart of mice with Lewis lung carcinoma compared with Dox treatment alone.MethodsHighly stable pristine C60 fullerene aqueous colloid solution (concentration 1.0\u00a0mg/ml, average hydrodynamic diameter of nanoparticles 50\u00a0nm) was used in the study and characterized by means of atomic force microscopy (AFM). The in vivo investigation of C60-Dox action was performed via the standard methods of histological and enzyme activity analyses.ResultsDox (total dose 2.5\u00a0mg/kg) combined with C60 fullerene (total dose 25\u00a0mg/kg) in tumor-bearing animals resulted in tumor growth inhibition, prolongation of life, metastasis inhibition, and increased number of apoptotic tumor cells and was more effective than the corresponding course of Dox treatment alone. C60 fullerene demonstrated a protective effect against superoxide dismutase and glutathione peroxidase inhibition induced by Dox-dependent oxidative insult in the liver and heart.ConclusionCombined treatment with C60\u00a0+\u00a0Dox is considered to be a promising approach for cancer chemotherapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s40268-014-0074-4", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.4896210", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1020803", 
        "issn": [
          "1174-5886", 
          "1179-6901"
        ], 
        "name": "Drugs in R&D", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "keywords": [
      "DOX treatment", 
      "Lewis lung carcinoma", 
      "tumor-bearing animals", 
      "hearts of mice", 
      "apoptotic tumor cells", 
      "tumor growth inhibition", 
      "prolongation of life", 
      "lung carcinoma", 
      "protective effect", 
      "ConclusionCombined treatment", 
      "glutathione peroxidase inhibition", 
      "antitumor effects", 
      "cell responses", 
      "cytostatic drugs", 
      "doxorubicin treatment", 
      "tumor cells", 
      "cancer chemotherapy", 
      "potent anticancer drug", 
      "antitumor potential", 
      "antioxidant enzyme activities", 
      "oxidative insult", 
      "metastasis inhibition", 
      "reactive oxygen species", 
      "vivo investigations", 
      "chemical insults", 
      "atomic force microscopy", 
      "superoxide dismutase", 
      "treatment", 
      "anticancer drugs", 
      "growth inhibition", 
      "insult", 
      "liver", 
      "inhibition", 
      "C60 fullerene", 
      "drugs", 
      "oxygen species", 
      "heart", 
      "successful use", 
      "DOX", 
      "peroxidase inhibition", 
      "colloid solution", 
      "BackgroundDoxorubicin", 
      "aqueous colloid solution", 
      "chemotherapy", 
      "carcinoma", 
      "enzyme activity", 
      "mice", 
      "prolongation", 
      "force microscopy", 
      "high toxicity", 
      "dismutase", 
      "study", 
      "toxicity", 
      "pristine C60", 
      "fullerenes", 
      "animals", 
      "antioxidants", 
      "standard methods", 
      "effect", 
      "cells", 
      "promising approach", 
      "enzyme activity analysis", 
      "aim", 
      "agents", 
      "activity analysis", 
      "use", 
      "course", 
      "response", 
      "C60", 
      "synergistic agent", 
      "activity", 
      "life", 
      "action", 
      "nanostructures", 
      "number", 
      "corresponding course", 
      "microscopy", 
      "potential", 
      "investigation", 
      "analysis", 
      "approach", 
      "solution", 
      "means", 
      "method", 
      "species", 
      "generation"
    ], 
    "name": "C60 Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment", 
    "pagination": "333-340", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045017571"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40268-014-0074-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25504158"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40268-014-0074-4", 
      "https://app.dimensions.ai/details/publication/pub.1045017571"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_637.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s40268-014-0074-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40268-014-0074-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40268-014-0074-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40268-014-0074-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40268-014-0074-4'


 

This table displays all metadata directly associated to this object as RDF triples.

299 TRIPLES      21 PREDICATES      136 URIs      120 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40268-014-0074-4 schema:about N02abc44dc54d4ced8417d54d70a63749
2 N13c3213a6b5e4adab5ebc337ab85277b
3 N18280322d7bc42998aa91402de5f7d7c
4 N1fe9ab5cb01c4f9ba8dd58b7b6ac8667
5 N2192619a4796406487bb65c34a05432a
6 N3b28b7259cc94655bf9c83e6c28cb061
7 N6137257ab4864d4aa86198f2ad24a289
8 N7370f4cf958c4f609f8b297446619885
9 N7bbb6e250ed3411782d06e91ff6a8eee
10 N8c1bf7d6528e491ab6b937a87566937a
11 Na4d3a476c3874d09af1ab7d0fe969dfb
12 Nb5944eb7ca8b4d1bba31425a36db09ab
13 Nb75309d562584d6eaa5be2f5316cf694
14 Nc41aff95019b4581a06234a93f02274c
15 Nc622e4ad57c74e618c8bee0b8efcdbae
16 Nd7f717701fad4c50966755be4b475fe1
17 Ne32bc011cd184d6d92c970ad93c1237c
18 anzsrc-for:11
19 anzsrc-for:1115
20 schema:author Nf84507085ccc4ae7866dca0009de544e
21 schema:citation sg:pub.10.1007/978-0-387-76713-0_13
22 sg:pub.10.1007/s00204-012-0859-6
23 sg:pub.10.1007/s00249-014-0960-2
24 sg:pub.10.1007/s11051-005-9001-5
25 sg:pub.10.1007/s11427-012-4387-7
26 sg:pub.10.1007/s12645-011-0020-x
27 sg:pub.10.1016/s1734-1140(09)70041-6
28 sg:pub.10.1186/1477-3155-4-14
29 schema:datePublished 2014-12-12
30 schema:datePublishedReg 2014-12-12
31 schema:description BackgroundDoxorubicin (Dox) is one of the most potent anticancer drugs, but its successful use is hampered by high toxicity caused mainly by generation of reactive oxygen species. One approach to protect against Dox-dependent chemical insult is combined use of the cytostatic drug with antioxidants. C60 fullerene has a nanostructure with both antioxidant and antitumor potential and may be useful in modulating cell responses to Dox.ObjectiveThe aim of this study was to estimate the antitumor effect and antioxidant enzyme activity of combined C60 fullerene and Dox (C60 + Dox) in the liver and heart of mice with Lewis lung carcinoma compared with Dox treatment alone.MethodsHighly stable pristine C60 fullerene aqueous colloid solution (concentration 1.0 mg/ml, average hydrodynamic diameter of nanoparticles 50 nm) was used in the study and characterized by means of atomic force microscopy (AFM). The in vivo investigation of C60-Dox action was performed via the standard methods of histological and enzyme activity analyses.ResultsDox (total dose 2.5 mg/kg) combined with C60 fullerene (total dose 25 mg/kg) in tumor-bearing animals resulted in tumor growth inhibition, prolongation of life, metastasis inhibition, and increased number of apoptotic tumor cells and was more effective than the corresponding course of Dox treatment alone. C60 fullerene demonstrated a protective effect against superoxide dismutase and glutathione peroxidase inhibition induced by Dox-dependent oxidative insult in the liver and heart.ConclusionCombined treatment with C60 + Dox is considered to be a promising approach for cancer chemotherapy.
32 schema:genre article
33 schema:isAccessibleForFree true
34 schema:isPartOf N5657f896dae447999e0aa8353b26f999
35 N9ede7773c53740d18b1974fc1e5c92e8
36 sg:journal.1020803
37 schema:keywords BackgroundDoxorubicin
38 C60
39 C60 fullerene
40 ConclusionCombined treatment
41 DOX
42 DOX treatment
43 Lewis lung carcinoma
44 action
45 activity
46 activity analysis
47 agents
48 aim
49 analysis
50 animals
51 anticancer drugs
52 antioxidant enzyme activities
53 antioxidants
54 antitumor effects
55 antitumor potential
56 apoptotic tumor cells
57 approach
58 aqueous colloid solution
59 atomic force microscopy
60 cancer chemotherapy
61 carcinoma
62 cell responses
63 cells
64 chemical insults
65 chemotherapy
66 colloid solution
67 corresponding course
68 course
69 cytostatic drugs
70 dismutase
71 doxorubicin treatment
72 drugs
73 effect
74 enzyme activity
75 enzyme activity analysis
76 force microscopy
77 fullerenes
78 generation
79 glutathione peroxidase inhibition
80 growth inhibition
81 heart
82 hearts of mice
83 high toxicity
84 inhibition
85 insult
86 investigation
87 life
88 liver
89 lung carcinoma
90 means
91 metastasis inhibition
92 method
93 mice
94 microscopy
95 nanostructures
96 number
97 oxidative insult
98 oxygen species
99 peroxidase inhibition
100 potent anticancer drug
101 potential
102 pristine C60
103 prolongation
104 prolongation of life
105 promising approach
106 protective effect
107 reactive oxygen species
108 response
109 solution
110 species
111 standard methods
112 study
113 successful use
114 superoxide dismutase
115 synergistic agent
116 toxicity
117 treatment
118 tumor cells
119 tumor growth inhibition
120 tumor-bearing animals
121 use
122 vivo investigations
123 schema:name C60 Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment
124 schema:pagination 333-340
125 schema:productId N79361ba0b82d47ec9756bb754d2d0308
126 N799bfb04d5d9418a8ca8d6063ea611b6
127 Nca1ba78278b14710acc4b2bae5866e67
128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045017571
129 https://doi.org/10.1007/s40268-014-0074-4
130 schema:sdDatePublished 2022-10-01T06:39
131 schema:sdLicense https://scigraph.springernature.com/explorer/license/
132 schema:sdPublisher Nc8c9dac1315f467c83e8ac82d198a254
133 schema:url https://doi.org/10.1007/s40268-014-0074-4
134 sgo:license sg:explorer/license/
135 sgo:sdDataset articles
136 rdf:type schema:ScholarlyArticle
137 N02abc44dc54d4ced8417d54d70a63749 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Doxorubicin
139 rdf:type schema:DefinedTerm
140 N13c3213a6b5e4adab5ebc337ab85277b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Heart
142 rdf:type schema:DefinedTerm
143 N18280322d7bc42998aa91402de5f7d7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Animals
145 rdf:type schema:DefinedTerm
146 N1fe9ab5cb01c4f9ba8dd58b7b6ac8667 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Drug Screening Assays, Antitumor
148 rdf:type schema:DefinedTerm
149 N2192619a4796406487bb65c34a05432a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Superoxide Dismutase
151 rdf:type schema:DefinedTerm
152 N3b28b7259cc94655bf9c83e6c28cb061 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Antineoplastic Agents
154 rdf:type schema:DefinedTerm
155 N5657f896dae447999e0aa8353b26f999 schema:volumeNumber 14
156 rdf:type schema:PublicationVolume
157 N5d036c2aeb05445ea8cfbfac7788430d rdf:first sg:person.01042167742.25
158 rdf:rest Nf4992a352b3d4b39bab1b3021703c06c
159 N6137257ab4864d4aa86198f2ad24a289 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Nanoparticles
161 rdf:type schema:DefinedTerm
162 N7370f4cf958c4f609f8b297446619885 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Drug Synergism
164 rdf:type schema:DefinedTerm
165 N79361ba0b82d47ec9756bb754d2d0308 schema:name doi
166 schema:value 10.1007/s40268-014-0074-4
167 rdf:type schema:PropertyValue
168 N799bfb04d5d9418a8ca8d6063ea611b6 schema:name pubmed_id
169 schema:value 25504158
170 rdf:type schema:PropertyValue
171 N7bbb6e250ed3411782d06e91ff6a8eee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Mice
173 rdf:type schema:DefinedTerm
174 N8c1bf7d6528e491ab6b937a87566937a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Carcinoma, Lewis Lung
176 rdf:type schema:DefinedTerm
177 N9ede7773c53740d18b1974fc1e5c92e8 schema:issueNumber 4
178 rdf:type schema:PublicationIssue
179 Na4d3a476c3874d09af1ab7d0fe969dfb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Fullerenes
181 rdf:type schema:DefinedTerm
182 Naeba4c0ad09243948966909946b1836e rdf:first sg:person.0616413475.06
183 rdf:rest Nf4297d2b97e342e9abfa6c93a4b43f75
184 Nb5944eb7ca8b4d1bba31425a36db09ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Glutathione Peroxidase
186 rdf:type schema:DefinedTerm
187 Nb75309d562584d6eaa5be2f5316cf694 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Male
189 rdf:type schema:DefinedTerm
190 Nba904491d60c4cfab421c9ff2286cd35 rdf:first sg:person.01340542173.15
191 rdf:rest Naeba4c0ad09243948966909946b1836e
192 Nc41aff95019b4581a06234a93f02274c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Antioxidants
194 rdf:type schema:DefinedTerm
195 Nc622e4ad57c74e618c8bee0b8efcdbae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Myocardium
197 rdf:type schema:DefinedTerm
198 Nc8c9dac1315f467c83e8ac82d198a254 schema:name Springer Nature - SN SciGraph project
199 rdf:type schema:Organization
200 Nc9d5c6223bfd440090460c594c31b987 rdf:first sg:person.0761452727.99
201 rdf:rest Nba904491d60c4cfab421c9ff2286cd35
202 Nca1ba78278b14710acc4b2bae5866e67 schema:name dimensions_id
203 schema:value pub.1045017571
204 rdf:type schema:PropertyValue
205 Nd7f717701fad4c50966755be4b475fe1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Liver
207 rdf:type schema:DefinedTerm
208 Ne32bc011cd184d6d92c970ad93c1237c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Colloids
210 rdf:type schema:DefinedTerm
211 Nf4297d2b97e342e9abfa6c93a4b43f75 rdf:first sg:person.0664526675.56
212 rdf:rest rdf:nil
213 Nf4992a352b3d4b39bab1b3021703c06c rdf:first sg:person.01037270327.44
214 rdf:rest Nc9d5c6223bfd440090460c594c31b987
215 Nf84507085ccc4ae7866dca0009de544e rdf:first sg:person.01265014537.58
216 rdf:rest N5d036c2aeb05445ea8cfbfac7788430d
217 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
218 schema:name Medical and Health Sciences
219 rdf:type schema:DefinedTerm
220 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
221 schema:name Pharmacology and Pharmaceutical Sciences
222 rdf:type schema:DefinedTerm
223 sg:grant.4896210 http://pending.schema.org/fundedItem sg:pub.10.1007/s40268-014-0074-4
224 rdf:type schema:MonetaryGrant
225 sg:journal.1020803 schema:issn 1174-5886
226 1179-6901
227 schema:name Drugs in R&D
228 schema:publisher Springer Nature
229 rdf:type schema:Periodical
230 sg:person.01037270327.44 schema:affiliation grid-institutes:grid.34555.32
231 schema:familyName Matyshevska
232 schema:givenName Olga
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037270327.44
234 rdf:type schema:Person
235 sg:person.01042167742.25 schema:affiliation grid-institutes:grid.34555.32
236 schema:familyName Grynyuk
237 schema:givenName Iryna
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042167742.25
239 rdf:type schema:Person
240 sg:person.01265014537.58 schema:affiliation grid-institutes:grid.34555.32
241 schema:familyName Prylutska
242 schema:givenName Svitlana
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265014537.58
244 rdf:type schema:Person
245 sg:person.01340542173.15 schema:affiliation grid-institutes:grid.445984.0
246 schema:familyName Evstigneev
247 schema:givenName Maxim
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340542173.15
249 rdf:type schema:Person
250 sg:person.0616413475.06 schema:affiliation grid-institutes:grid.6553.5
251 schema:familyName Scharff
252 schema:givenName Peter
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616413475.06
254 rdf:type schema:Person
255 sg:person.0664526675.56 schema:affiliation grid-institutes:grid.6553.5
256 schema:familyName Ritter
257 schema:givenName Uwe
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664526675.56
259 rdf:type schema:Person
260 sg:person.0761452727.99 schema:affiliation grid-institutes:grid.34555.32
261 schema:familyName Prylutskyy
262 schema:givenName Yuriy
263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761452727.99
264 rdf:type schema:Person
265 sg:pub.10.1007/978-0-387-76713-0_13 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044141474
266 https://doi.org/10.1007/978-0-387-76713-0_13
267 rdf:type schema:CreativeWork
268 sg:pub.10.1007/s00204-012-0859-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028227274
269 https://doi.org/10.1007/s00204-012-0859-6
270 rdf:type schema:CreativeWork
271 sg:pub.10.1007/s00249-014-0960-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008871525
272 https://doi.org/10.1007/s00249-014-0960-2
273 rdf:type schema:CreativeWork
274 sg:pub.10.1007/s11051-005-9001-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026397920
275 https://doi.org/10.1007/s11051-005-9001-5
276 rdf:type schema:CreativeWork
277 sg:pub.10.1007/s11427-012-4387-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027441736
278 https://doi.org/10.1007/s11427-012-4387-7
279 rdf:type schema:CreativeWork
280 sg:pub.10.1007/s12645-011-0020-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041423305
281 https://doi.org/10.1007/s12645-011-0020-x
282 rdf:type schema:CreativeWork
283 sg:pub.10.1016/s1734-1140(09)70041-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035189147
284 https://doi.org/10.1016/s1734-1140(09)70041-6
285 rdf:type schema:CreativeWork
286 sg:pub.10.1186/1477-3155-4-14 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032470725
287 https://doi.org/10.1186/1477-3155-4-14
288 rdf:type schema:CreativeWork
289 grid-institutes:grid.34555.32 schema:alternateName Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601, Kyiv, Ukraine
290 schema:name Joint Ukrainian-German Center on Nanobiotechnology, Kyiv, Ukraine
291 Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601, Kyiv, Ukraine
292 rdf:type schema:Organization
293 grid-institutes:grid.445984.0 schema:alternateName Department of Biology and Chemistry, Belgorod State University, 85 Pobedy Str., 308015, Belgorod, Russia
294 schema:name Department of Biology and Chemistry, Belgorod State University, 85 Pobedy Str., 308015, Belgorod, Russia
295 rdf:type schema:Organization
296 grid-institutes:grid.6553.5 schema:alternateName Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer Str. 25, 098693, Ilmenau, Germany
297 schema:name Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer Str. 25, 098693, Ilmenau, Germany
298 Joint Ukrainian-German Center on Nanobiotechnology, Kyiv, Ukraine
299 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...